Synchrony Financial Form 144/A details 8,000-share planned sale
Rhea-AI Filing Summary
Synchrony Financial (SYF) has a holder planning to sell 8,000 shares of its common stock under a Form 144/A notice. The planned sale is through Raymond James & Associates on the NYSE, with an approximate sale date of 11/03/2025 and an aggregate market value of $590,663.65. The filing notes that there were 371,900,000 shares of this class outstanding at the time shown. The shares being sold were previously acquired as compensation from the issuer on several dates, and the seller represents that they do not know of any undisclosed material adverse information about the issuer’s operations.
Positive
- None.
Negative
- None.
FAQ
What does the SYF Form 144/A filing disclose?
The Form 144/A filing for Synchrony Financial (SYF) discloses a planned sale of 8,000 shares of SYF common stock by a holder, including details on the broker, exchange, and how and when the shares were acquired.
How many SYF shares are planned to be sold and what is their market value?
The holder plans to sell 8,000 shares of Synchrony Financial common stock with an aggregate market value of $590,663.65, according to the Form 144/A disclosure.
Which broker and exchange are involved in the SYF Form 144/A sale?
The planned sale will be executed through Raymond James & Associates, located in St. Petersburg, Florida, and the shares are to be sold on the NYSE as stated in the filing.
How many Synchrony Financial shares were outstanding according to this notice?
The Form 144/A notice reports 371,900,000 shares of common stock outstanding for Synchrony Financial for the class of securities referenced.
How were the SYF shares being sold under Form 144/A originally acquired?
The shares covered by the notice were acquired as compensation from the issuer on multiple dates, with specific acquisition dates and amounts listed for each block of common stock.
What representation does the selling holder make in the SYF Form 144/A?
By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Synchrony Financial’s current or prospective operations that has not been publicly disclosed.